Practice Certificate Independent Prescribing

Key facts

  • Start date: March & June
  • Accreditation: We're accredited by the General Pharmaceutical Council to provide courses in independent prescribing
  • Application deadline: 1 February & 1 May
  • Study mode and duration: Part-time - distance learning, pre-residential course activity, two residential periods and a period of learning in practice

Study with us

Studying a Practice Certificate Independent Prescribing at the University of Strathclyde in Glasgow, you'll be learning at an award-winning, 5-star QS-rated university.

Back to course

Why this course?

We're accredited by the General Pharmaceutical Council (GPhC) to provide courses in independent prescribing (IP).

Successful completion of the course will result in the award of a Practice Certificate in Independent Prescribing.

The course of study involves:

  • pre-residential course activity
  • distance learning material
  • two residential periods
  • a period of learning in practice, under the supervision of a designated medical practitioner.

You'll be awarded 30 ScotCat credits on completion of the course.

Pharmacist looking at drugs on a shelf

What you'll study

  • therapeutics from a choice of cardiovascular, respiratory disease, diabetes, substance misuse and renal medicine
  • communicating with patients & colleagues
  • prescribing & public health
  • care planning

You'll also undertake a Period of Learning in Practice (PLP). The aim is to provide you with opportunities to develop competencies in prescribing. This period focuses on the patient group(s) in which you'll be expecting to prescribe.

Course dates

March 2020

Residential dates

  • 1 to 5 June
  • 27 August

Closing date for applications is 1 February

June 2020

  • 31 August to 4 September
  • 10 December (TBC)

Closing date for applications is 1 May

QS five stars logo 2019

We're a 5-star
QS-rated University

Go back

Course content

The course of study involves pre-residential course activity, distance learning material, two residential periods and a period of learning in practice, under the supervision of a designated medical practitioner. You'll be awarded 30 ScotCat credits on completion of the course.

Assessment

Distance learning – completed before the first residential period

  • Therapeutics Assessment – MCQ and short answer
  • Prescribing and public health – short-answer

Residential period 1

  • Formative OSCE for the care planning class

Distance learning – completed after the first residential period

  • Reflective essay on the formative OSCE
  • Reflective short scenarios on communicating with patients and colleagues

Residential period 2

  • Summative OSCE for the care planning class
Residential study

This element of the course is at Scottish Masters (SHEM) level 5 throughout. It's delivered through two residential periods that are taught here at the University of Strathclyde.

The first residential period of five days includes four classes, worth five credits each:

  • therapeutics from a choice of cardiovascular, respiratory disease, diabetes, substance misuse and renal medicine
  • communicating with patients & colleagues
  • prescribing & public health
  • care planning

Full attendance during the residential period is essential. 

The second residential period (one day) will normally take place approximately 12 weeks after the first residential period. It involves peer review sessions designed to demonstrate clinical and ethical practice.

Period of Learning in Practice (PLP)

The aim is to provide you with opportunities to develop competencies in prescribing. This period focuses on the patient group(s) in which you'll be expecting to prescribe. The PLP starts after the first residential period. 

The PLP is made up of a series of sessions (combination of full and/or half days) that involve prescribing and clinical activities. This should equate to a minimum of 12 days (90 hours), but is subject to decision by the pharmacist and their supervisor based on the challenges of the individual prescribing roles being adopted by different pharmacists.

This PLP time will be used to develop clinical skills including:

  • accurate assessment
  • history-taking
  • recognition and response to common signs and symptoms 
  • formulation of a working diagnosis

During this period you'll be supervised by a designated medical prescriber who will be responsible for confirming your competence to practice.

A portfolio providing evidence that the required time has been spent and the learning outcomes achieved will be submitted along with a statement of assessment from the designated medical supervisor.

The assessment will confirm the pharmacist's clinical competence in the area(s) for which they intend to prescribe.

The period in practice will normally be completed within 12 months of the residential course. 

Designated medical practitioner requirements

The designated medical practitioner must be able to confirm that they:

  • have had at least three years medical, treatment and prescribing responsibility for a group of patients in the relevant field of practice
  • work within a GP Practice or are a specialist registrar, clinical assistant or a consultant within an NHS Trust or other NHS employer
  • have some experience or training in teaching and/or supervision in practice
  • agree to provide supervision, support and shadowing opportunities, and are familiar with the requirements of the programme
  • will assess the progress of the pharmacist
Back to course

Entry requirements

All pharmacists must meet the following requirements:

  • current registration with GPhC &/or PSNI as a practising pharmacist
  • be in good standing with the healthcare regulator with which they are registered
  • have at least two years appropriate patient orientated experience post registration, in a relevant UK setting
  • have an identified area of clinical or therapeutic practice in which to develop independent prescribing practice and have relevant clinical or  therapeutic experience in that area
  • demonstrate how they reflect on their own performance and take responsibility for their own CPD
  • demonstrate how they will develop their own networks for support, reflection and learning, including prescribers from other professions
  • have a designated prescribing practitioner who has agreed to supervise their period of learning in practice
Back to course

Fees & funding

2020/21

Scotland/EU

2019/20 - £2,200

2020/21 - £2,300

Rest of UK

2019/20 - £2,200

2020/21 - £2,300

Funding

Applications for funding can be made through NHS Education for Scotland (NES). Those who are not being funded by NES should contact the course organiser directly before completing the applications form to arrange a telephone interview.

A full refund (less a £50 administration charge) will be given if a cancellation request is received more than seven days before commencement of a course.

No refunds for cancellations received within seven days will be given unless in exceptional circumstances.

No refunds will be given after the commencement of a course.

Transfer to another course may be considered subject to availability. If you have to withdraw after the commencement of a course on medical grounds, a medical certificate must be provided. Upon receipt of this, a transfer or refund will be issued.

Please note: the fees shown are annual and may be subject to an increase each year. Find out more about fees.

Back to course

Apply

Independent Prescribing - March

Qualification: Pract-cert
Start Date: Mar 2020
Mode of Delivery: part-time

Independent Prescribing - June

Qualification: Pract-cert
Start Date: Jun 2020
Mode of Delivery: part-time

Back to course

Contact us

Derna Campbell

Course Director

Telephone: 00441415482450

Email: derna.campbell@strath.ac.uk

Strathclyde Institute of Pharmacy and Biomedical Sciences
161 Cathedral Street
Glasgow
G4 0RE